National Coalition for LGBTQ Health
Home » Resource Library

Op-Ed: After Pride, Mpox Still Deserves Attention

Read the just published op-ed by the Coalition’s Scott Bertani: “After Pride: Mpox Still Deserves Attention,” in The Standard Palm Springs.

Related Resources

Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.

JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S.

View Resource

Fact Sheet: Update on the Biden-⁠Harris Administration’s Commitment to Addressing the Global Mpox Outbreak

Archived update from the White House from December 2024. During the 2022 global outbreak of clade II mpox, the Biden-Harris Administration mounted a robust response by making vaccines, tests, and treatment available to those at risk in the United States and abroad.

View Resource
Access This Resource
Resource Type
Subject Areas
Associated Programs
Share This Resource
National Coalition for LGBTQ Health

1630 Connecticut Ave. NW, Suite 500
Washington, DC 20009

202-232-6749 | [email protected]

Main Menu
Advocacy Learning Research About the Coalition
Additional Resources
HealthHIV HealthHCV PleasePrEPMe.org SYNChronicity Conference

© Copyright 2025 National Coalition for LGBTQ Health. All rights reserved. | Privacy Policy | Site Map